Management of connective tissue disease-associated interstitial lung disease
The management of connective tissue diseases (CTD)-associated interstitial lung disease (ILD) is challenging considering its myriad presentations and variable course. Evidence to guide treatment is insufficient with very few randomized trials reported till date. This review discusses the current evi...
Saved in:
Main Author: | Keerthi Talari |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2021;volume=16;issue=5;spage=87;epage=91;aulast=Talari |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Connective tissue disease-associated interstitial lung disease – A multicenter observational study from India
by: Sham Santhanam, et al.
Published: (2021-01-01) -
Updates in the management of connective tissue disease-associated interstitial lung disease
by: Chengappa Kavadichanda, et al.
Published: (2021-01-01) -
Imaging in connective tissue disease-associated interstitial lung disease
by: Praveen P G. Rao, et al.
Published: (2021-01-01) -
Descriptive study of the role of ultrasound in the evaluation of patients with interstitial lung disease associated with autoimmune connective tissue disorders
by: Varghese Koshy, et al.
Published: (2023-01-01) -
Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01)